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Summary The report contrasts the ascertainment of cases by the regional cancer registry with a specially
designed search for records and pathology material which was then submitted to critical review irrespective of
the original diagnosis. Boundary changes over the intervening years were accounted for and the results
contrasted between time periods and with the cancer registry records. A large proportion of cancer registry
cases were never subjected to histopathological diagnosis and comparisons between the new data and records
are not easy to undertake. The study describes a probable true rise in the incidence of follicular non-
Hodgkin's lymphoma in certain parts of Yorkshire over the last 20 years; there is less evidence of a similar
change in Hodgkin's disease incidence over the same period of time.
Knowledge of changing trends in lymphoma
incidence, whether geographical or temporal, may
provide important insights into the aetiology of
these malignancies. These data are normally
provided by cancer registrations. Some information
on lymphoma incidence is available on an
international basis (Waterhouse et al., 1982) and
annual reviews of registrations for England and
Wales are produced by the Office of Population
Censuses and Surveys (OPCS, 1978-85). Mortality
figures are also provided over longer periods but
their value in relation to disease incidence is
restricted due to the significant change in survival
of lymphoma patients in recent years. Certain
limitations are also attached to the use of standard
incidence figures from lymphoma registration which
necessitate caution in their interpretation. This is
the result both of inaccuracy and lack of resolution
of the data. Inaccuracy may occur at source due to
difficulties in establishing a reliable pathological
diagnosis (Bird et al., 1984). It can also be due to
incorrect registration of cases; this will vary with
time as registration procedures have become more
efficient since cancer registries were first established
30 years ago. Very little is known about the past or
present efficiency of cancer registration, or how
accurately cancer registry figures reflect the true
incidence of neoplastic diseases.
Examination of the figures published by OPCS
for the Yorkshire Health Region (OPCS, 1978)
appear to suggest that there has been an
approximate doubling in the registration rate of
non Hodgkin's lymphoma between 1968 and 1980,
while for Hodgkin's disease the rate has remained
constant in males and doubled in females. These
trends are also observed nationally with Hodgkin's
disease incidence remaining constant while other
malignant neoplasms of lymphoid and histiocytic
tissue (ICD-9 202) doubling. There has, however,
been a considerable fall in cases registered as
lymphosarcoma or reticulosarcoma (ICD-9 200)
since 1975. If verified, and not merely the result of
changing registration practice these dramatic
changes in lymphoma incidence over such a short
time span may provide important clues about the
aetiology of these malignancies. However, in view
of the uncertainties concerning the accuracy of
cancer registry data, it is clearly essential to confirm
there has been a genuine change in lymphoma
incidence during the past 20 years.
For this reason we have undertaken a
retrospective analysis of all lymphomas and related
conditions occurring in four separate health
districts within the Yorkshire Health Region during
1963-67 and 1978-82 to confirm the accuracy of
diagnosis and registration.
Methods
Health districts studied
Four out of the seventeen district health authorities
(A, B, C and D) within the modern boundaries of
the Yorkshire Health Region were selected for
study. Adjustments were made to the population
included to ensure that any changes in health
district boundaries resulting from reorganisations in
1974 and 1982 did not invalidate the study groups.
The districts were chosen to represent as wide an
urban: rural spectrum as possible but also where
the hospital and laboratory records were known to
be complete for the periods under study. Three of
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the districts have one central pathology department
serving all hospitals in the district and the fourth
has a main department with a small satellite
department in another hospital. District B is
situated in a rural area containing several small
country towns, district D is completely urban and
districts A and C contain both urban and rural
areas.
Case ascertainment
Cases included in the four health districts for 1978-
82 were obtained from the Yorkshire Regional
Lymphoma Registry (Bird et al., 1984). The data
were checked for completeness with Cancer
Registry records and supplemented from a regional
case-control epidemiological study of leukaemia
and lymphomas currently in progress (Bernard et
al., 1984). Any histological material from cases not
previously referred to the Panel was retrieved and
diagnoses reviewed and standardised according to
the criteria employed by the Panel. Cases occurring
during 1963-67 with residential addresses in the
four health districts, whether or not they had been
treated in those health districts, were identified
from the Cancer Registry. Histological material was
retrieved from appropriate hospitals and an
additional search was made of laboratory records
in each hospital to identify cases that might have
escaped correct registration. These included lymph
node biopsies recorded as containing anaplastic
tumour or exhibiting reactive hyperplasia, as well as
those cases correctly diagnosed as lymphoma but
for some reason not referred to the Cancer
Registry. The review diagnoses were made by Panel
members without knowledge of the original
diagnosis. Hodgkin's disease (HD) cases were
classified according to the Rye system (Lukes &
Butler, 1966) and non-Hodgkin's lymphoma (NHL)
according to the British National Lymphoma
Investigation System (Bennett et al., 1974).
Cases between 1963 and 1967 found from
searching laboratory records and not recorded in
the Cancer Registry were re-checked for earlier
registration which might indicate the onset of
disease prior to 1963. Cases where histopathological
material could not be traced were included under
their original diagnosis for the calculation of
incidence rates and assessment of effectiveness of
cancer registration, but they were excluded when
considering the change in relative proportion of
different histological subtypes between the two time
periods.
District population studied
In order to calculate incidence rates it was
necessary to estimate the populations of the four
health districts annually within the two time
periods. This involved estimating the annual mid
year population for the years 1963-67 and 1978-82.
contained within post-1982 health district
boundaries. All population figures were obtained
from OPCS via the Yorkshire Regional Health
Authority Statistics Department. For the period
1978-82 annual figures were available by age and
sex for the four health districts. However, from
1963-67 only mid-year estimates of total population
were available from which the populations within
the health district boundaries could be calculated.
To obtain an age-sex structure for these years it
was necessary to extrapolate the total mid-year
populations in terms of the age structure of these
districts at the 1961 Census. This was accomplished
by multiplying the mid-year estimate of total
population for each district by the fraction of the
total population that each age and sex group
represented at the 1961 Census. All four districts
show a marked ageing of the population between
the two time periods. The proportion of older
people in the population is further increased in
districts A and D by a fall in the number of
children (<15 years), whereas in districts B and C
this has remained approximately constant. In order
to make the incidence rates comparable between the
two time periods and between districts they were
standardised by age and sex. This was achieved by
applying the crude age and sex specific rates to a
standard population, thus eliminating any potential
error due to differing age and sex structures in the
base population of each health district or between
the two time periods. The population used for this
purpose was that of England and Wales at the 1981
Census.
Results
Review diagnoses
Histological material from 1,112 cases during the
1963-67 period was reviewed; 313 cases were found
to be lymphoma, of these confirmed lymphomas
252 (81%) cases were found to have been correctly
classified at the time of original diagnosis according
to the major class of lymphoma (HD or NHL) and
33 (11%) were regarded as being of the alternate
lymphoma class (Table I). Relatively few cases
(28:9%) were considered to have been
misdiagnosed originally as reactive hyperplasia or
anaplastic carcinoma. In addition 50 cases
originally thought to be lymphoma were found to
have different diagnoses on review. Table I also
indicates how errors are distributed between the
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Table I Comparison ofconfirmed lymphomas: original diagnosis with final diagnosis: 1963-67
No. ofconfirmed lymphomas originally classified as:
Same Alternate
District health Confirmed lymphoma lymphoma
authority lymphomas class class Not lymphoma
A 111 88 (79.3) 11 (9.9) 12 (10.8)
B 52 40 (76.9) 7 (13.5) 5 (9.6)
C 57 46 (80.7) 6 (10.5) 5 (8.8)
D 94 78 (83.9) 9 (9.7) 6 (6.5)
Total 313a 252 (80.5) 33 (10.5) 28 (9.0)
aExcluding 29 cases where histological material was not available.
Table II Lymphoma incidence: different health districts during 1963-67 and 1978-82
Standardised Standardised
Hodgkin's disease non-Hodgkin's lymphoma
incidencea Difference incidencea DifJerence
incidence incidence
Authority 1963-67 1978-82 rates pb 1963-67 1978-82 rates pb
A 1.96 2.38 +0.42 0.22 5.37 6.46 + 1.09 0.12
B 1.63 1.94 +0.31 0.32 4.91 5.27 +0.36 0.37
C 2.27 2.96 +0.69 0.16 4.64 8.77 +4.13 <0.0001
D 1.51 2.20 +0.69 0.07 4.51 6.94 +2.43 0.001
Total 1.84 2.37 +0.53 0.04 4.86 6.86 +2.00 <0.0001
aStandardised for age and sex with the population of England and Wales in
population per year. bStatistical analysis described in appendix.
1981 and expressed as cases 100,000
During 1978-82 a total of 520 lymphoma cases
were identified, of which 131 (25.2%) were
considered to show features of HD and 384 (73.8%)
NHL. Five cases could not be further classified.
Incidence rates
As shown in Table II, incidence rates for the
combined district health authorities reveal an
overall increase between 1963-67 and 1978-82 both
for HD and NHL. For HD this increase for the
combined health districts was statistically significant
(P<0.04), although no single district showed a
significant increase. In the case of NHL the
combined districts show a highly significant
increase (P<0.0001), with considerable variation
between individual districts but no relationship to
urban or rural environments.
The age distributions of the two classes of
lymphoma for the two periods are shown in
Figures 1 and 2. HD shows a bimodal age
distribution with peaks in early adult life and over
60 years of age while NHL shows a progressive
increase with age. Comparison of the earlier and
later time periods reveals that for patients with HD
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Figure 1 Age distribution of Hodgkin's disease in the
combined Health Districts. (-) 1963-67; ( ) 1978-82.
over 65 years of age the incidence is higher during
the 1978-82 period. Since this reflects the age
specific rate, the increase is independent of the
process of ageing of the total population. In
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Figure 2 Age distribution of non-Hodgkin's
lymphoma in the combined Health Districts. (-)
1963-67; (---)1978-82.
contrast, a much more general increase in incidence
is observed in NHL above the age of 30 years.
Changed histological subtypes: 1963-67 and 1978-82
Table III shows the overall change in the number
and relative proportion of histological subtypes of
HD and NHL during the study period. It is
apparent that there has been an increase in all
forms of HD and NHL. In the case of HD the
greatest increase is displayed by the lymphocyte
depletion subtype (+4.5%) and the largest decrease
by the mixed cellularity subtype (-3.9%).
However, none of these changes reaches statistical
significance.
For NHL the greatest increase is displayed by
follicular lymphomas whereas diffuse forms tend to
show a relative decrease. Although overall these
changes were statistically significant, none of the
individual subtypes of NHL shows a statistically
significant change.
Table III Change in histological subtypes of lymphoma during 1963-67 and 1978-82
No. cases (%)'
Differenceb
Histological subtype 1963-67 1978-82 proportion pg
Hodgkin's disease
Nodular sclerosis 49 (62.0) 81 (62.3) +0.3 0.97
Lymphocyte predominance 11 (13.9) 17 (13.1) -0.8 0.87
Mixed cellularity 14 (17.7) 18 (13.8) -3.9 0.45
Lymphocyte depletion 5 (6.3) 14 (10.8) +4.5 0.28
Total 79 (100)' 130 (100)d
Follicular Non-Hodgkin's lymphoma
Small follicle cell 17 (7.5) 44 (11.7) +4.2 0.10 1
Mixed small and large follicle cell 17 (7.5) 44 (11.7) +4.2 0.10 0.03h
Large follicle cell 4 (1.8) 4 (1.1) -0.07 0.47 J
Diffuse
Small lymphocytic 26 (11.4) 39 (10.4) -1.0 0.68
Intermediate lymphocytic 20 (8.8) 33 (8.8) 0.0 0.99
Poorly differentiated lymphocytic 21 (9.3) 29 (7.7) -1.6 0.51 003h
Mixed small and large lymphocytic 51 (22.5) 68 (18.1) -4.3 0.19
Large undifferentiated cell 69 (30.4) 107 (28.5) -1.9 0.61
Mycosis fungoides 2 (0.9) 8 (2.1) +1.2 0.25 J
Total 227 (100)C 376 (100)f
aFive cases excluded in each time period where the lymphoma subtype could not be identified.
bDifference in the proportion of cases occurring in 1978-82 and 1963-67. cExcludes 11 cases where
histological material was not available for review. dExcludes 1 case where histological material was
not available for review. 'Excludes 20 cases where histological material was not available for review.
fExcludes 8 cases where histological material was not available for review. gStatistical analysis
described in appendix. hOverall probability.RISING INCIDENCE OF LYMPHOID TUMOURS? 397
Effectiveness of cancer registration
Table IV shows the total number of cases registered
as lymphomas with the Cancer Registry and the
proportion falling into different diagnostic groups
on review. The Cancer Registry data included a
remarkably consistent group of registrations at the
two time periods (16.9% and 16.6%) from which it
would appear no diagnostic material was ever
taken. In addition to the data shown in Table IV
which exclusively records cases registered by the
Cancer Registry as lymphoma, a further 82 cases in
1963-67 and 42 cases in 1978-82 were histologically
confirmed by our study as being lymphomas but
had escaped correct registration. The bulk of these
cases were not registered at all, although some cases
are registered as other malignancies or as
lymphomas but in other years.
Table V shows the effect of these inaccuracies on
the incidence rates calculated for those
malignancies. It can be seen that in 1963-67 HD is
over-registered and NHL under-registered. Overall
the total lymphoma incidence calculated from the
Cancer Registry and pathologically confirmed data
is relatively similar, but constructed of different
cases. A similar pattern is observed for the 1978-82
period except that greater over-registration with the
Cancer Registry occurred. Those cases which lack
biopsy or other diagnostic material were excluded
from the histologically confirmed groups but
included in the 'cancer registry' columns of this
table.
Discussion
The results of this study confirm that there has
been a considerable increase in the incidence of
lymphomas during the past 20 years in the
Yorkshire Region. This increase is more marked for
NHL than for HD and these changes in incidence
are independent of any change in the age and sex
structure of the population under study. Although a
rise in the incidence of HD and NHL was observed
in all health districts studied the increase was more
apparent in two of these. The reasons for
differences between one health district and another
are not readily apparent. They do not appear to be
related to the urban/rural content of each district as
district C (displaying the greatest increase) is
predominantly rural while district D (with the
second greatest increase) is completely urban. The
smallest increase is displayed by the completely
rural district B. It is felt that these increases are
genuine and not the result of differing methods of
data collection occurring in the two time periods.
Loss of cases through treatment at other hospitals
in the early time period is unlikely to play an
important part, particularly in district C where
greatest changes were observed as this hospital is a
centre for a large rural area and more likely to gain
than lose cases. This is not felt to be a problem in
the later period where more accurate recording of
the entire Yorkshire Region is available. The two
graphs (Figures 1 and 2) indicate the age-specific
rates. They show an overall increase in NHL over
Table IV Review diagnosis of cases registered as lymphoma with cancer registry
Lymphoma
Registered Diagnosis class Not Never
Time period as lymphoma confirmed altered lymphoma biopsied
No. cases (%)
1963-67 366 230 (62.8) 30 (8.2) 44 (12.0) 62 (16.9)
1978-82 603 457 (75.8) 21 (3.5) 25 (4.1) 100 (16.6)
Table V Age and sex standardised incidence rates (using the 1981 England and Wales
population) for histologically confirmed and cancer registry data
Rates/100,000/year
1963-67 1978-82
Histologically Cancer Histologically Cancer
Disease confirmed registry confirmed registry
Hodgkin's disease 1.84 2.55 2.37 2.61
Non-Hodgkin's lymphoma 4.86 4.56 6.86 6.38
Total lymphoma 6.81 7.22 9.33 10.89398 N. BARNES et al.
the age of 30 but an excess in HD confined to the
older age groups.
A striking feature of these results, is the increase
in the incidence of follicular lymphoma amongst
the NHL. It is noteworthy that the reproducibility
by expert lymphoma panel pathologists is best for
the follicular lymphomas (NCI, 1985). This adds to
our confidence that this is likely to be a real
change. The reasons for this have still to be
ascertained and a large case-control epidemiological
study is currently underway, in which differences in
environmental factors are being addressed.
The findings in this study also indicate that
incidence figures for lymphoma derived from
Cancer Registry data should be interpreted with
considerable caution. Our results show that more
than a quarter of lymphomas in the first time
period have been incorrectly registered, and 8%
were incorrectly recorded in the second time period.
Despite the apparent improvement in computed
registration, incidence rates for these two conditions
are still too high in this later time period due to the
failure of registries to control the registration of
histologically unproven cases. Although such
conclusions can strictly be applied to the Yorkshire
Registry alone for the time periods under study we
believe they reflect a more general pattern of cancer
registration.
Our findings also emphasise the necessity in
studies of lymphoma epidemiology to have
adequate pathological control. Our figures reveal
that even in a country like the United Kingdom
with a well established health service and long
established recording procedures unexpurgated
lymphoma incidence data cannot be accepted at
face value. The scale of such problems at an
international level is unknown but seems likely to
be considerably more.
Appendix
In Table II the statistical analysis was performed using a
modified form of Cochran's test for the difference between
two proportions a=p'A-PB
where d ZNAPAi -PB)
ENi
( NM var(di)
var(J)= Z
(ENi)2
Ni =Number in each age/sex strate of the standard
population
PAi =incidence rate in each age/sex strata in 1978-82.
PBi =incidence rate in each age/sex strata in 1963-67.
In Table III the statistical analysis performed assuming U
to be a standardised normale deviate where
U pl-p2
{pqK-f
and PI=-
nl
p =r,+r2
q =l-p
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